- Previous Close
3.8200 - Open
3.8400 - Bid 3.8500 x --
- Ask 3.8600 x --
- Day's Range
3.7800 - 3.9000 - 52 Week Range
3.1700 - 5.1400 - Volume
1,435,050 - Avg. Volume
3,225,681 - Market Cap (intraday)
1.224B - Beta (5Y Monthly) 0.13
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1500 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 22, 2018
- 1y Target Est
--
Tiansheng Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and circulation activities. It offers products in various categories, including respiratory, digestive, cardiovascular and cerebrovascular, pediatric, gynecological, orthopedic, oncology, hepatobiliary, blood, surgery, diabetes, and others. The company was founded in 2001 and is based in Chongqing, China.
www.tszy.com.cnRecent News: 002872.SZ
View MorePerformance Overview: 002872.SZ
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002872.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002872.SZ
View MoreValuation Measures
Market Cap
1.22B
Enterprise Value
1.34B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.13
Price/Book (mrq)
0.60
Enterprise Value/Revenue
2.32
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-8.27%
Return on Assets (ttm)
-1.18%
Return on Equity (ttm)
-2.33%
Revenue (ttm)
575.3M
Net Income Avi to Common (ttm)
-47.6M
Diluted EPS (ttm)
-0.1500
Balance Sheet and Cash Flow
Total Cash (mrq)
243.03M
Total Debt/Equity (mrq)
19.24%
Levered Free Cash Flow (ttm)
-22.03M